AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2021

Nov 23, 2021

30786_dirs_2021-11-23_d62b0491-746e-4e65-a7a3-2740abdb652a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-11-09

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-09	Bio-Rad B Common Stock	G	20	$.00	Acquired	316146	Direct
2021-11-09	Bio-Rad B Common Stock	G	20	$.00	Acquired	12858	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	423670	Direct
Bio-Rad B Common Stock	4060054	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.